Related Experiment Videos
Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry
Maureen M J Guichelaar1, Michael Malinchoc, Jean Sibonga
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Hepatology (Baltimore, Md.)
|September 26, 2002
Summary
Cholestatic osteopenia in liver diseases like primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) involves reduced bone formation and increased resorption, particularly in women. Further research is needed to clarify causes.
Area of Science:
- Bone Biology
- Hepatology
- Metabolic Bone Disease
Background:
- Cholestatic osteopenia is a significant clinical issue in liver diseases.
- The underlying mechanisms of cholestatic osteopenia remain poorly understood.
Purpose of the Study:
- To investigate bone resorption and formation in patients with advanced cholestatic liver diseases.
- To compare histomorphometric changes in primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC).
Main Methods:
- Prospective evaluation of 50 patients undergoing liver transplantation.
- Tetracycline-labeled histomorphometric analysis of bone biopsies.
- Dual-energy X-ray absorptiometry (DXA) for bone mineral density.
Main Results:
- Histomorphometry revealed low bone volume and decreased bone formation rates, with normal mineralization.
- Increased osteoclast numbers and eroded surface areas indicated heightened bone resorption, especially in female patients.
- Bone changes were similar in PBC and PSC, suggesting chronic cholestasis as the cause.
Conclusions:
- Cholestatic osteopenia results from decreased bone formation and increased resorption, with sex-specific differences.
- The precise etiology and relative contribution of these factors require further investigation.